COMPANY

Argá Medtech

Argá Medtech is developing a generation, non-thermal, cardiac ablation system. From company website Source · Oct 12, 2026

Keywords: Atrial Fibrillation Persistant Atrial Fibrillation Paroxysmal AF Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

Sep 10, 2025 Trial start Not phased (device or behavioral study): Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation source ↗
Oct 11, 2022 Trial start Not phased (device or behavioral study): Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation source ↗

Upcoming milestones

2027-06 (ESTIMATED) · Not phased · Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation · NCT06784466

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT06784466	Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation	Not phased (device or behavioral study)	Recruiting	Sep 10, 2025	2027-06 (estimated)
NCT05572047	Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation	Not phased (device or behavioral study)	Active, not recruiting	Oct 11, 2022	2026-04 (estimated)